ARTICLE | Company News
Aradigm, Novo Nordisk deal
July 10, 2006 7:00 AM UTC
The companies again expanded their diabetes deal, resulting in payments of $27.5 million to ARDM, including $12 million for IP related to inhaled insulin. ARDM will retain exclusive, royalty-free righ...